{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:44:38Z","timestamp":1759538678678,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.joms.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T11:44:33Z","timestamp":1466163873000},"page":"2403-2408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review"],"prefix":"10.1016","volume":"74","author":[{"given":"Lindsay L.","family":"Graves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan V.","family":"Bukata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nona","family":"Aghazadehsanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal R.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur H.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2016.06.003_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/07357907.2015.1047506","article-title":"Quality and outcomes of treatment of hypercalcemia of malignancy","volume":"19","author":"Wright","year":"2015","journal-title":"Cancer Invest"},{"key":"10.1016\/j.joms.2016.06.003_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bone.2012.10.016","article-title":"Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls","volume":"52","author":"Schilcher","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.joms.2016.06.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: Second report of the task of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2016.06.003_bib4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"93","author":"Puhaindran","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.joms.2016.06.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11005\/jbm.2015.22.1.1","article-title":"Pathogenesis, management and prevention of atypical femoral fractures","volume":"22","author":"Im","year":"2015","journal-title":"J Bone Metab"},{"issue":"suppl 1","key":"10.1016\/j.joms.2016.06.003_bib6","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/BOT.0000000000000073","article-title":"Atypical femur fractures","volume":"28","author":"Borrelli","year":"2014","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.joms.2016.06.003_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cger.2014.01.010","article-title":"Atypical femur fractures","volume":"30","author":"Tyler","year":"2014","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.joms.2016.06.003_bib8","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.003_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-011-1429-y","article-title":"Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II\/III breast cancer","volume":"127","author":"Coleman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.joms.2016.06.003_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","article-title":"Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies","volume":"112","author":"Fehm","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.joms.2016.06.003_bib11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.24119","article-title":"Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients","volume":"115","author":"Walter","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2016.06.003_bib12","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2016.06.003_bib13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"American Society for Bone and Mineral Research: Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2016.06.003_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.joms.2008.11.005","article-title":"Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates","volume":"67","author":"Grasko","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.003_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.joms.2016.06.003_bib16","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","article-title":"Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw","volume":"22","author":"Compston","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2016.06.003_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.11005\/jbm.2014.21.2.155","article-title":"Atypical femoral fracture combined with osteonecrosis of the jaw during osteoporosis treatment with bisphosphonate","volume":"21","author":"Won","year":"2014","journal-title":"J Bone Metab"},{"key":"10.1016\/j.joms.2016.06.003_bib18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/RLU.0000000000000746","article-title":"Concurrent bisphosphonate-related bilateral atypical subtrochanteric fractures and osteonecrosis of the jaw on bone scintigraphy","volume":"40","author":"Kim","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.joms.2016.06.003_bib19","doi-asserted-by":"crossref","first-page":"E723","DOI":"10.1210\/jc.2012-4144","article-title":"Atypical femoral fractures shortly after osteonecrosis of the jaw in postmenopausal woman taking alendronate for osteoporosis","volume":"98","author":"Chiu","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239116302464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239116302464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:51:15Z","timestamp":1759510275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239116302464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0278239116302464"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2016.06.003","relation":{},"ISSN":["0278-2391"],"issn-type":[{"type":"print","value":"0278-2391"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of the American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}